InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by BRADSHER NEAL C, Director. Director active across 1 company, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 2 reports have been published. Activity tracked since 25 June 2021. The latest transaction was filed on 25 June 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
24,720 shares@ US$2.200.011% mcap50.0% of flowCommon SharesSEC:0000919574-21-004286:0
24,720 shares@ US$2.2050.0% of flowCommon SharesSEC:0000919574-21-004286
2 of 2 declarations
About BRADSHER NEAL C
Neal C. Bradsher is a Board Member at Lineage Cell Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
